Small Drinking Water Systems
Small drinking water systems are businesses or premises that supply their own water, typically through a private well or cistern, and allow the public access to the water, such as:
- Restaurants
- Wineries
- Hotels / motels
- Seasonal trailer parks or campgrounds
- Places of worship
- Recreational facilities
- Municipal airports and offices
- Public washrooms
Niagara Region Public Health and Emergency services is required to routinely inspect these systems, respond to adverse water quality incidents and investigate complaints.
Taking a water sample
Disinfect a system
When water sample results show the presence of bacteria (Total Coliforms and/or E. coli), it is necessary to disinfect the well/cistern and resample. These pathogens may have been introduced during maintenance, alterations, repairs, or they may indicate that surface water is entering the well/cistern.
A disinfection process is used to inactivate these bacteria. If repeat samples continue to show contamination, a treatment system may be required or the current treatment system is not working properly.
Contact
Contact us at 905-688-8248 ext. 7590 or by email at inspect@niagararegion.ca.
Reporting forms
- Notice of adverse test results and issue resolution
For licensed laboratories and owners / operators to provide notice of adverse water quality incidents and resolutions - Notice to reopen a seasonal facility
For seasonal premises to provide notice of when they intend to reopen - Laboratory services notification
For owners / operators to identify which licensed laboratories will test their mandatory drinking water samples - Notice to operate or reopen a small drinking water system
For owners / operators to report the location of their drinking water system to Public Health
Resources
- Well records map
Search a map to view well record information by address or well number - Small drinking water systems legislation
How to disinfect a cistern
- Step 1: Inspect your cistern
- Step 2: Disinfect the well
- Step 3: Resample
- Step 4: Continued adverse results